Discontinuation report PRADAXA
| Report ID | 255171 |
| Drug Identification Number | 02312433 |
| Brand name | PRADAXA |
| Common or Proper name | Pradaxa 75mg 3x10 |
| Company Name | BOEHRINGER INGELHEIM (CANADA) LTD LTEE |
| Market Status | MARKETED |
| Active Ingredient(s) | DABIGATRAN ETEXILATE |
| Strength(s) | 75MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL ORAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 3x10 |
| ATC code | B01AE |
| ATC description | ANTITHROMBOTIC AGENTS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2025-12-15 |
| Actual discontinuation date | |
| Remaining supply date | 2025-12-15 |
| Discontinuation status | To be discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | Current on Hand expected to cover demand to December 2025 based on 12 months historical sales. No further inventory to be received. |
| Company comments | Pradaxa 110mg 6x10s and Pradaxa 150mg 6x10s remains available |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 5180 SOUTH SERVICE ROAD BURLINGTON, ONTARIO CANADA L7L 5H4 |
| Company contact information | 1800 263 2425 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2025-04-17 | French | Compare |
| v1 | 2025-04-17 | English | Compare |
Showing 1 to 2 of 2